NCT00059293

Brief Summary

To use transcranial Doppler (TCD) ultrasound to detect stroke risk in children with sickle cell disease.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2002

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2002

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2003

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2003

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
Last Updated

May 4, 2018

Status Verified

July 1, 2008

Enrollment Period

5.8 years

First QC Date

April 22, 2003

Last Update Submit

May 3, 2018

Conditions

Eligibility Criteria

Age1 Year - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Study Population

The BABY HUG Follow-up Study I was an observational study to provide structured monitoring of the subjects enrolled in the BABY HUG Treatment Study, to initiate characterization of the long-term toxicities and unexpected risks (if any) associated with treatment with hydroxyurea at an early age, and any potential benefits of therapy.

No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Hematologic DiseasesAnemia, Sickle CellCerebrovascular DisordersIntracranial Embolism and Thrombosis

Condition Hierarchy (Ancestors)

Hemic and Lymphatic DiseasesAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesThromboembolismEmbolism and Thrombosis

Study Officials

  • Robert Adams

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2003

First Posted

April 24, 2003

Study Start

September 1, 2002

Primary Completion

July 1, 2008

Study Completion

July 1, 2008

Last Updated

May 4, 2018

Record last verified: 2008-07